Navigating Medicare Drug Pricing Negotiations

This chapter explores the intricacies of drug pricing negotiations within Medicare plans, emphasizing significant price reductions for medications like Genuvia and Entresto. It examines the varying industry responses, investor sentiments, and the implications for the upcoming election cycle. The chapter highlights the relevance of these negotiations in shaping drug pricing policies and voter perceptions as the political landscape evolves.